Causal Attributions in Breast Cancer Patients Planning to Undergo Adjuvant Endocrine Therapy.
Seul Ki ParkYul Ha MinMinsun LeeSae Byul LeePublished in: International journal of environmental research and public health (2021)
The aim of this study was to explore causal attributions among Korean breast cancer patients who were planning to undergo adjuvant endocrine therapy (AET) as well as the relationships between patient demographic and clinical characteristics and their causal attributions. Causal attributions were assessed with an open-ended response item, which asked patients to list what they thought were the three most important causal factors of their illness. The relationships between patient characteristics and causal attributions were determined through univariate analysis, and the relationships between causal attributions were obtained using social network analysis. A total of 299 participants provided 707 responses. Stress, diet, and exercise were believed to be the three most likely causes of breast cancer. There were no significant differences between causal attributions and the age, education level, marital status, or cancer stage of patients. However, there were differences in the associations between personality, genetics, and reproductive history and patient-identified causal attributions according to the patients' family history of cancer. Patients with a family history of cancer were more likely to believe that personality and genetics/family history were causes of breast cancer compared to patients without such a history. Therefore, it is necessary to educate patients to perceive stress and lifestyle-related factors as modifiable causal factors in order to have a positive effect on their adherence to AET.
Keyphrases
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- healthcare
- peritoneal dialysis
- squamous cell carcinoma
- physical activity
- cardiovascular disease
- stem cells
- patient reported outcomes
- weight loss
- mental health
- network analysis
- mesenchymal stem cells
- young adults
- high intensity
- patient reported
- childhood cancer
- replacement therapy